Overview

What they do
BlueStone Venture Partners is a life science venture capital fund investing in entrepreneurial companies. The fund provides strategic capital and support to early-stage life science companies, primarily in Series A and Series B equity rounds. It focuses on medical devices, health IT, advanced materials, and molecular diagnostics. Mara Aspinall and Thomas Nickoloff launched the venture capital fund in Tucson, Arizona in 2018.
bluestonevp.com
What they look for
BlueStone invests in specific verticals within the life sciences, partnering with businesses in the Southwest innovation ecosystem where there is strong research infrastructure but a dearth of venture capital support.
bluestonevp.com
Stage
Seed, Series A, Series B+
bluestonevp.com
Sectors
Healthcare
bluestonevp.com
Based
Tucson, US
bluestonevp.com

Sources

2026-08-30bluestonevp.comBlueStone Venture Partners is a best-in-class life sciences venture capital fund capitalizing…
2026-08-30bluestonevp.comBlueStone invests in companies that operate in specific verticals within the Life Sciences.…
2026-08-30bluestonevp.comStage of Financing Needed, Select, Seed Series A Series B Other
2026-08-30bluestonevp.comTom Nickoloff Co-Founder & Managing Director Tom Nickoloff, Founder & Managing Director, is…

Portfolio, cheque size and the rest

The companies they have backed, the cheque they write, and whether they are deploying right now.

Start free, no cardFree accounts see every record.